BCL9 and neoplasm: In the WNT/β-catenin signaling pathway, a high impact (premature stop codon) mutation (VAF = 0.010 in HCC cell line to VAF = 0.047 in HCC tumor) and missense mutation (VAF = 0.028 in HCC tumor) in BCL9 was identified.